P. Lizotte

发表

Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer

J. Mesirov, E. Lander, P. Tamayo, 2011, Proceedings of the National Academy of Sciences.

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies

Ellen T. Gelfand, Thomas M Green, J. Mesirov, 2014, Scientific Data.

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Paul J. Hoover, Carl G. de Boer, John P. Ray, 2018, Cell.

Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes.

C. Paweletz, Guocheng Yuan, P. Jänne, 2016, JCI insight.

STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models

D. Mooney, P. Lizotte, D. Barbie, 2022, bioRxiv.

Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.

Henry W. Long, R. Beroukhim, C. Paweletz, 2020, Cancer cell.

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation.

C. Paweletz, G. Freeman, Kwok-Kin Wong, 2017, Cancer discovery.

Cytotoxic T Cells in PD-L1–Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors

P. Jänne, P. Hammerman, A. Bass, 2016, Cancer Immunology Research.

Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study

P. Lizotte, C. Dumitru, A. Spira, 2021, Frontiers in Oncology.

Fine needle aspirate flow cytometric phenotyping characterizes immunosuppressive nature of the mesothelioma microenvironment

P. Hammerman, A. Bass, Kwok-Kin Wong, 2016, Scientific Reports.

In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer

P. Lizotte, N. Steinmetz, S. Fiering, 2015, Nature nanotechnology.

Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity.

C. Paweletz, M. Tolstorukov, E. V. Van Allen, 2021, Cancer discovery.

Erratum: Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma (Cell (2018) 175(4) (998–1013.e20), (S0092867418313941) (10.1016/j.cell.2018.10.038))

Paul J. Hoover, Carl G. de Boer, John P. Ray, 2019 .

Neoadjuvant and Adjuvant Nivolumab and Lirilumab in Patients with Recurrent, Resectable Squamous Cell Carcinoma of the Head and Neck

C. Paweletz, A. Egloff, R. Tishler, 2021, Clinical Cancer Research.

Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck.

P. Hammerman, Kwok-Kin Wong, P. Lizotte, 2017, Oral oncology.

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Paul J. Hoover, Carl G. de Boer, John P. Ray, 2019, Cell.

Stimulating antitumor immunity with nanoparticles.

P. Lizotte, S. Fiering, M. R. Sheen, 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

Immune-Mediated Regression of Established B16F10 Melanoma by Intratumoral Injection of Attenuated Toxoplasma gondii Protects against Rechallenge

P. Lizotte, S. Fiering, M. Bosenberg, 2013, The Journal of Immunology.

This information is current as against Rechallenge Protects Toxoplasma gondii of Attenuated InjectionB 16 F 10 Melanoma by Intratumoral Immune-Mediated Regression of Established

P. Lizotte, S. Fiering, M. Bosenberg, 2012 .

Attenuated Listeria monocytogenes reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis

P. Lizotte, S. Fiering, P. Lauer, 2014, Oncoimmunology.

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer.

C. Paweletz, P. Jänne, J. Köhler, 2022, Cancer cell.

STING activation promotes robust immune response and NK cell–mediated tumor regression in glioblastoma models

P. Lizotte, D. Barbie, Lanlan Zhou, 2021, bioRxiv.

False-Positive Plasma Genotyping Due to Clonal Hematopoiesis

C. Paweletz, P. Jänne, Kwok-Kin Wong, 2018, Clinical Cancer Research.

SQSTM1 is a pathogenic target of 5q copy number gains in kidney cancer.

C. Sander, P. Tamayo, R. Beroukhim, 2013, Cancer cell.

TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy.

G. Freeman, Kwok-Kin Wong, P. Lizotte, 2018, JCI insight.

Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade.

C. Paweletz, P. Hammerman, P. Lizotte, 2020, The Journal of clinical investigation.

Frameshift events predict anti-PD-1/L1 response in head and neck cancer.

L. Macconaill, P. Lizotte, N. Chau, 2018, JCI insight.

Optimal Targeting of HER 2 – PI 3 K Signaling in Breast Cancer : Mechanistic Insights and Clinical Implications

A. Schetter, S. Groshen, E. Bowman, 2013 .

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Zhi Wei, Hongye Liu, Wei Huang, 2018, Cancer discovery.

A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing

P. Jänne, N. Gray, P. Lizotte, 2018, Cancer Immunology Research.

Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy

Joshua D. Campbell, A. Bass, Kwok-Kin Wong, 2020, Clinical Cancer Research.

Acute pharmacological degradation of Helios destabilizes regulatory T cells

N. Gray, P. Lizotte, P. Gokhale, 2021, Nature Chemical Biology.

Phase II study of pembrolizumab in refractory esophageal cancer with correlates of response and survival

Jeffrey W. Clark, A. Bass, C. Fuchs, 2021, Journal for ImmunoTherapy of Cancer.

Activation of tumor-cell STING primes NK-cell therapy.

C. Paweletz, M. Tolstorukov, W. Richards, 2022, Cancer immunology research.

Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-Small Cell Lung Cancer.

Guocheng Yuan, P. Hammerman, Kwok-Kin Wong, 2017, Cancer discovery.

MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer

C. Paweletz, P. Janne, P. Lizotte, 2022, Cancer research.

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies

Pablo Tamayo, Aviad Tsherniak, Ted Liefeld, 2014, Scientific Data.

Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment.

P. Lizotte, S. Fiering, J. Cubillos-Ruiz, 2013, Cancer research.

Pre-T cell receptor self-MHC sampling restricts thymocyte dedifferentiation

E. Reinherz, P. Lizotte, W. Hwang, 2022, bioRxiv.

Development of a Patient-Derived 3D Immuno-Oncology Platform to Potentiate Immunotherapy Responses in Ascites-Derived Circulating Tumor Cells

P. Lizotte, D. Barbie, D. Dinulescu, 2023, Cancers.